These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3801500

  • 1. Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid.
    Koopman BJ, Wolthers BG, van der Molen JC, Nagel GT, Kruizinga W.
    Biochim Biophys Acta; 1987 Feb 14; 917(2):238-46. PubMed ID: 3801500
    [Abstract] [Full Text] [Related]

  • 2. Increased (23R)-hydroxylase activity in patients suffering from cerebrotendinous xanthomatosis, resulting in (23R)-hydroxylation of bile acids.
    Koopman BJ, Wolthers BG, Van der Molen JC, Nagel GT, Rutgers H, Strijtveen B, Kaptein B.
    Biochim Biophys Acta; 1986 Oct 01; 883(3):585-92. PubMed ID: 3756224
    [Abstract] [Full Text] [Related]

  • 3. Capillary gas chromatographic determinations of urinary bile acids and bile alcohols in CTX patients proving the ineffectivity of ursodeoxycholic acid treatment.
    Koopman BJ, Wolthers BG, van der Molen JC, Nagel GT, Waterreus RJ, Oosterhuis HJ.
    Clin Chim Acta; 1984 Sep 15; 142(1):103-11. PubMed ID: 6478619
    [Abstract] [Full Text] [Related]

  • 4. Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment.
    Batta AK, Arora R, Salen G, Tint GS, Eskreis D, Katz S.
    J Lipid Res; 1989 Dec 15; 30(12):1953-62. PubMed ID: 2621422
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification of short side chain bile acids in urine of patients with cerebrotendinous xanthomatosis.
    Kuramoto T, Furukawa Y, Nishina T, Sugimoto T, Mahara R, Tohma M, Kihira K, Hoshita T.
    J Lipid Res; 1990 Oct 15; 31(10):1895-902. PubMed ID: 2079611
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Capillary gas chromatography of urine samples in diagnosing cerebrotendinous xanthomatosis.
    Bouwes Bavinck JN, Vermeer BJ, Gevers Leuven JA, Koopman BJ, Wolthers BG.
    Arch Dermatol; 1986 Nov 15; 122(11):1269-72. PubMed ID: 3777973
    [Abstract] [Full Text] [Related]

  • 11. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.
    Batta AK, Salen G, Arora R, Shefer S, Tint GS, Abroon J, Eskreis D, Katz S.
    Hepatology; 1989 Oct 15; 10(4):414-9. PubMed ID: 2777202
    [Abstract] [Full Text] [Related]

  • 12. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Berginer VM, Salen G, Shefer S.
    N Engl J Med; 1984 Dec 27; 311(26):1649-52. PubMed ID: 6504105
    [Abstract] [Full Text] [Related]

  • 13. Serum bile acid profiles in cerebrotendinous xanthomatosis.
    Beppu T, Seyama Y, Kasama T, Serizawa S, Yamakawa T.
    Clin Chim Acta; 1982 Feb 05; 118(2-3):167-75. PubMed ID: 7055978
    [Abstract] [Full Text] [Related]

  • 14. Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid.
    Salen G, Tint GS, Eliav B, Deering N, Mosbach EH.
    J Clin Invest; 1974 Feb 05; 53(2):612-21. PubMed ID: 11344576
    [Abstract] [Full Text] [Related]

  • 15. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography.
    Batta AK, Shefer S, Batta M, Salen G.
    J Lipid Res; 1985 Jun 05; 26(6):690-8. PubMed ID: 4031647
    [Abstract] [Full Text] [Related]

  • 16. Reduction of urinary bile alcohol excretion and serum cholestanol in patients with cerebrotendinous xanthomatosis after oral administration of deoxycholic acid.
    Wolthers BG, van der Molen JC, Walrecht H, Hesselmans LF.
    Clin Chim Acta; 1990 Dec 14; 193(3):113-8. PubMed ID: 2282689
    [Abstract] [Full Text] [Related]

  • 17. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
    Nakagawa M, Colombo C, Setchell KD.
    Hepatology; 1990 Aug 14; 12(2):322-34. PubMed ID: 2391071
    [Abstract] [Full Text] [Related]

  • 18. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis.
    Stiehl A, Rudolph G, Raedsch R, Möller B, Hopf U, Lotterer E, Bircher J, Fölsch U, Klaus J, Endele R.
    Hepatology; 1990 Sep 14; 12(3 Pt 1):492-7. PubMed ID: 2401455
    [Abstract] [Full Text] [Related]

  • 19. Case of cerebrotendinous xanthomatosis. I: Unusual ophthalmic features.
    Morgan SJ, McKenna P, Bosanquet RC.
    Br J Ophthalmol; 1989 Dec 14; 73(12):1011-4. PubMed ID: 2611184
    [Abstract] [Full Text] [Related]

  • 20. Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.
    Batta AK, Salen G, Tint GS.
    Metabolism; 2004 May 14; 53(5):556-62. PubMed ID: 15131757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.